Diabetologia:荷兰建立1型糖尿病并发症预测模型

2014-09-04 王英 生物通

最近发表在Diabetologia (欧洲糖尿病研究协会期刊)的一项最新研究,提出了一种新的模型,可通过简单、常规测量的危险因子预测哪些1型糖尿病患者将会出现严重的并发症。本研究是由荷兰瓦格宁根大学助理教授Sabita Soedamah-Muthu及其同事完成。 为了制备这个模型,研究人员分析了EURODIAB前瞻性并发症研究中的1973名1型糖尿病患者的7年数据,将主要并发症

最近发表在Diabetologia (欧洲糖尿病研究协会期刊)的一项最新研究,提出了一种新的模型,可通过简单、常规测量的危险因子预测哪些1型糖尿病患者将会出现严重的并发症。本研究是由荷兰瓦格宁根大学助理教授Sabita Soedamah-Muthu及其同事完成。

为了制备这个模型,研究人员分析了EURODIAB前瞻性并发症研究中的1973名1型糖尿病患者的7年数据,将主要并发症的预后因素与一个计算机模型结合。1型糖尿病的主要并发症包括:严重的冠心病、中风、终末期肾衰竭、截肢、失明和全因死亡率。95名EURODIAB 1型糖尿病患者在随访期间出现了主要并发症。主要并发症的预后因素是年龄、糖化血红蛋白、腰臀比、白蛋白/肌酸酐比值和HDL-(好)胆固醇。

研究人员分别在三个不同的前瞻性队列中:匹兹堡糖尿病并发症流行病学研究 (EDC, USA, n=554)、芬兰糖尿病肾病研究 (FinnDiane, Finland, n=2,999)和1型糖尿病研究中的冠状动脉分类(CACTI, USA, n=580),检测了该模型的性能。在对一些队列中主要并发症的预测性和观察性因素之间的系统差异进行校正后,该模型能够准确地预测患者的风险。作者称:“该模型能够很好地将表现主要并发症的患者和不会表现主要并发症的患者,区分开来。在收集关于患者年龄、糖化血红蛋白、腰臀比、白蛋白-肌酐比值和高密度脂蛋白胆固醇的信息后,健康保健专业人员可将这些信息,输入到所提供的评分表中,它将自动算出1型糖尿病患者主要并发症的3、5和7年绝对风险。”

他们补充说:“1型糖尿病患者中的绝对风险预测,对于及时发现严重并发症高风险患者,以预防这些并发症的发展并降低医疗费用,是很重要的。此外,该预测模型对于告知患者和选择高危人群用于随机对照试验(RCTs),具有重要的作用。”

作者强调,该模型可以通过处理所有可改变的危险因素,用来帮助高危患者。他们说:“预测主要的并发症,可让我们建立1型糖尿病患者的风险分析。医生可能会考虑对所确定的高危患者采取积极干预。这些干预措施包括,根据现有的指导方针,强化胰岛素治疗方案和心血管风险管理。更详细地说,这些结果将有助于确定哪些风险最大的患者,从而帮助集中干预治疗。这种干预的例子包括胰岛素、口服降糖药、ACE抑制剂、血管紧张素受体阻滞剂、他汀类药物、饮食和生活方式管理。”

原始出处:

Sabita S. Soedamah-Muthu, Yvonne Vergouwe, Tina Costacou, Rachel G. Miller, Janice Zgibor, Nish Chaturvedi, Janet K. Snell-Bergeon, David M. Maahs, Marian Rewers, Carol Forsblom, Valma Harjutsalo, Per-Henrik Groop, John H. Fuller, Karel G. M. Moons, Trevor J. Orchard.Predicting major outcomes in type 1 diabetes: a model development and validation study.Diabetologia.September 2014

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=20612, encodeId=63932061208, content=糖尿病肾病进展风险的关系没有发现。, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:20:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757633, encodeId=bbfd1e5763399, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Tue Oct 21 16:55:00 CST 2014, time=2014-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636936, encodeId=efed1636936cd, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 16 20:55:00 CST 2014, time=2014-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262706, encodeId=ca311262e0642, content=<a href='/topic/show?id=52941002359d' target=_blank style='color:#2F92EE;'>#预测模型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100235, encryptionId=52941002359d, topicName=预测模型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Sat Sep 06 00:55:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413013, encodeId=6b6c1413013f3, content=<a href='/topic/show?id=315de670091' target=_blank style='color:#2F92EE;'>#糖尿病并发症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76700, encryptionId=315de670091, topicName=糖尿病并发症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6712920539, createdName=axin010, createdTime=Sat Sep 06 00:55:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759489, encodeId=f29b1e5948929, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sun May 03 01:55:00 CST 2015, time=2015-05-03, status=1, ipAttribution=)]
    2015-04-11 x35042875

    糖尿病肾病进展风险的关系没有发现。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=20612, encodeId=63932061208, content=糖尿病肾病进展风险的关系没有发现。, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:20:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757633, encodeId=bbfd1e5763399, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Tue Oct 21 16:55:00 CST 2014, time=2014-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636936, encodeId=efed1636936cd, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 16 20:55:00 CST 2014, time=2014-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262706, encodeId=ca311262e0642, content=<a href='/topic/show?id=52941002359d' target=_blank style='color:#2F92EE;'>#预测模型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100235, encryptionId=52941002359d, topicName=预测模型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Sat Sep 06 00:55:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413013, encodeId=6b6c1413013f3, content=<a href='/topic/show?id=315de670091' target=_blank style='color:#2F92EE;'>#糖尿病并发症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76700, encryptionId=315de670091, topicName=糖尿病并发症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6712920539, createdName=axin010, createdTime=Sat Sep 06 00:55:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759489, encodeId=f29b1e5948929, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sun May 03 01:55:00 CST 2015, time=2015-05-03, status=1, ipAttribution=)]
    2014-10-21 丁鹏鹏
  3. [GetPortalCommentsPageByObjectIdResponse(id=20612, encodeId=63932061208, content=糖尿病肾病进展风险的关系没有发现。, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:20:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757633, encodeId=bbfd1e5763399, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Tue Oct 21 16:55:00 CST 2014, time=2014-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636936, encodeId=efed1636936cd, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 16 20:55:00 CST 2014, time=2014-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262706, encodeId=ca311262e0642, content=<a href='/topic/show?id=52941002359d' target=_blank style='color:#2F92EE;'>#预测模型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100235, encryptionId=52941002359d, topicName=预测模型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Sat Sep 06 00:55:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413013, encodeId=6b6c1413013f3, content=<a href='/topic/show?id=315de670091' target=_blank style='color:#2F92EE;'>#糖尿病并发症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76700, encryptionId=315de670091, topicName=糖尿病并发症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6712920539, createdName=axin010, createdTime=Sat Sep 06 00:55:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759489, encodeId=f29b1e5948929, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sun May 03 01:55:00 CST 2015, time=2015-05-03, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=20612, encodeId=63932061208, content=糖尿病肾病进展风险的关系没有发现。, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:20:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757633, encodeId=bbfd1e5763399, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Tue Oct 21 16:55:00 CST 2014, time=2014-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636936, encodeId=efed1636936cd, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 16 20:55:00 CST 2014, time=2014-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262706, encodeId=ca311262e0642, content=<a href='/topic/show?id=52941002359d' target=_blank style='color:#2F92EE;'>#预测模型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100235, encryptionId=52941002359d, topicName=预测模型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Sat Sep 06 00:55:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413013, encodeId=6b6c1413013f3, content=<a href='/topic/show?id=315de670091' target=_blank style='color:#2F92EE;'>#糖尿病并发症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76700, encryptionId=315de670091, topicName=糖尿病并发症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6712920539, createdName=axin010, createdTime=Sat Sep 06 00:55:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759489, encodeId=f29b1e5948929, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sun May 03 01:55:00 CST 2015, time=2015-05-03, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=20612, encodeId=63932061208, content=糖尿病肾病进展风险的关系没有发现。, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:20:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757633, encodeId=bbfd1e5763399, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Tue Oct 21 16:55:00 CST 2014, time=2014-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636936, encodeId=efed1636936cd, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 16 20:55:00 CST 2014, time=2014-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262706, encodeId=ca311262e0642, content=<a href='/topic/show?id=52941002359d' target=_blank style='color:#2F92EE;'>#预测模型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100235, encryptionId=52941002359d, topicName=预测模型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Sat Sep 06 00:55:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413013, encodeId=6b6c1413013f3, content=<a href='/topic/show?id=315de670091' target=_blank style='color:#2F92EE;'>#糖尿病并发症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76700, encryptionId=315de670091, topicName=糖尿病并发症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6712920539, createdName=axin010, createdTime=Sat Sep 06 00:55:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759489, encodeId=f29b1e5948929, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sun May 03 01:55:00 CST 2015, time=2015-05-03, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=20612, encodeId=63932061208, content=糖尿病肾病进展风险的关系没有发现。, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:20:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757633, encodeId=bbfd1e5763399, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Tue Oct 21 16:55:00 CST 2014, time=2014-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636936, encodeId=efed1636936cd, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 16 20:55:00 CST 2014, time=2014-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262706, encodeId=ca311262e0642, content=<a href='/topic/show?id=52941002359d' target=_blank style='color:#2F92EE;'>#预测模型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100235, encryptionId=52941002359d, topicName=预测模型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Sat Sep 06 00:55:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413013, encodeId=6b6c1413013f3, content=<a href='/topic/show?id=315de670091' target=_blank style='color:#2F92EE;'>#糖尿病并发症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76700, encryptionId=315de670091, topicName=糖尿病并发症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6712920539, createdName=axin010, createdTime=Sat Sep 06 00:55:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759489, encodeId=f29b1e5948929, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sun May 03 01:55:00 CST 2015, time=2015-05-03, status=1, ipAttribution=)]
    2015-05-03 智智灵药

相关资讯

ADA首次发布T1DM立场声明 儿童HbA1c标准为7.5%

  在6月16日ADA的第74届科学会议上召开新闻发布会,首次发布了针对全年龄1型糖尿病的立场声明,其中包括儿童的糖化血红蛋白(HbA1c)管理目标。 统一儿童HbA1c标准为7.5% 新的儿童血糖管理目标是将全年龄患儿的HbA1c控制在低于7.5%的水平,取代了既往不同年龄儿童不同控制目标(6岁以下儿童低于8.5%,6-12岁儿童低于8%,13-19岁儿童低于7.5%

毕宇芳:从流行病学研究透视中国糖尿病流行特点

2型糖尿病是全球范围内一项持续增长的威胁,据IDF2013数据统计,全球约3.82亿糖尿病人口,90%为2型糖尿病病;所有糖尿病患者中,46%未得到及时针对,早期防控面临严峻挑战。无论高或低收入国家,2型糖尿病患病率均随年龄增长逐渐增加,且高收入与中等收入国家的2型糖尿病患病率显著高于低收入国家。 我国正经历城镇化快速转型的过程,生活环境与生活方式均发生巨大转变,流行病学研究显示,1980年

儿童2型糖尿病,防控具有自身特点

一、儿童糖尿病,2型渐成主角 随着生活水平的提高和生活方式的转变,糖尿病大军正以前所未有的惊人速度发展壮大。根据最新的统计资料,我国成人糖尿病患病率达11.6%,糖尿病前期率为50.1%,照此估算,我国约有1.139亿糖尿病患者及近5亿糖尿病前期人群。近年来,由于肥胖儿童的增多,在以中老年为主体的2型糖尿病队伍中,出现了越来越多天真稚嫩的面孔。长期以来,一直认为儿童糖尿病多为1型,而

Diabetes Care:口服醋甲唑胺或可治疗2型糖尿病

澳大利亚一项研究显示,醋甲唑胺是2型糖尿病新干预方式的原型(archetype),其临床获益超过了血糖控制。论文于8月14日在线发表于《糖尿病护理》(Diabetes Care)杂志。 研究介绍 此项双盲、安慰剂对照试验将76例患者随机纳入口服醋甲唑胺组和安慰剂组,治疗24周。醋甲唑胺治疗的主要有效性终点为24周后安慰剂校正的糖化血红蛋白(HbA1c )水平较基线的降低(ΔHbA1

JBJS:糖尿病关节置换术前糖化血红蛋白不一定能降至7%以下

在美国,接受关节置换的病例中约8.5%为糖尿病患者。而糖尿病是关节置换术后各种并发症和死亡的危险因素之一,血糖控制不佳会加大此风险。 糖化血红蛋白(HbA1c)水平是衡量糖尿病控制是否良好的标准之一。研究发现HbA1c > 7.0%者术后并发症率明显增加,但与术后深部感染并无特别关系。 美国学者Giori NJ等所在医院从2004年10月1日起对所有拟行全关节置换的糖尿病患者常规检测术前

JCEM:唾液检测可早期筛查2型糖尿病

美国威尔康乃尔医学院研究人员发现,通过检测唾液中的1,5-脱水葡萄糖醇(1,5-AG)水平有助于更早识别出高危人群中的2型糖尿病患者。 研究者入选188例已确诊2型糖尿病的患者和181例已知糖尿病的受试者,发现其唾液中的1,5-AG水平与2型糖尿病强烈相关,唾液中的1,5-AG水平与血液中的1,5-AG水平高相关,都与血糖和糖化血红蛋白水平负相关。研究者指出,唾液1,5-AG水平是短期血糖控